药明康德公告,截至2025年6月末,公司持续经营业务在手订单人民币566.9亿元,同比增长37.2%。报告期内,公司持续经营收入人民币204.1亿元,其中来自美国客户收入人民币140.3亿元,同比增长38.4%;来自欧洲客户收入人民币23.3亿元,同比增长9.2%;来自中国客户收入人民币31.5亿元,同比下降5.2%;来自其他地区客户收入人民币9.0亿元,同比增长7.6%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.